Skip to main content

Month: April 2024

CAPREIT Announces April 2024 Distribution

TORONTO, April 15, 2024 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX: CAR.UN) announced today its April 2024 monthly distribution in the amount of $0.12084 per Unit (or $1.45 on an annualized basis). The April 2024 distribution will be payable on May 15, 2024 to Unitholders of record at the close of business on April 30, 2024. CAPREIT is Canada’s largest publicly traded provider of quality rental housing. As at December 31, 2023, CAPREIT owns approximately 64,300 residential apartment suites, townhomes and manufactured home community sites well-located across Canada and the Netherlands, with approximately $16.5 billion of investment properties in Canada and Europe. Since its Initial Public Offering in May 1997, CAPREIT has grown monthly cash distributions per Unit by 103%. For more...

Continue reading

Extendicare Announces April 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, April 15, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of April 2024, which is payable on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors’ population. We operate a network of 125 long-term care homes...

Continue reading

PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement

Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and PetPlus Membership, 52% of total revenue, up from 42% at the same time last year.Strong balance sheet with $49.4 million of cashThe Company is now current in all of its SEC filings DELRAY BEACH, Fla., April 15, 2024 (GLOBE NEWSWIRE) — PetMed Express, Inc. (NASDAQ: PETS)(“PetMeds” or “Company”), Your Trusted Pet Health ExpertTM, today announced its financial results for its third quarter of fiscal year 2024, restated financial statements for the years ended March 31, 2023, 2022 and 2021, and interim financial statements for previously reported quarterly periods in 2023 and 2022. Quarterly HighlightsNet sales for the quarter ended December 31, 2023, were $65.3 million, compared to $58.9 million for...

Continue reading

Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Business Combination with TOYO Solar Pending A Post-Effective Amendment to The Registration Statement

New York, April 15, 2024 (GLOBE NEWSWIRE) — Blue World Acquisition Corporation (“Blue World”) (NASDAQ: BWAQ) today announced that it postponed the extraordinary general meeting (the “Extraordinary General Meeting”) pending the Post-Effective Amendment (as defined below) in connection with the proposed business combination (the “Business Combination”) between Blue World and Vietnam Sunergy Cell Company Limited, a Vietnamese company (“TOYO Solar”). Prior to the Extraordinary General Meeting, TOYO Co., Ltd, a Cayman Islands exempted company and the parent of TOYO Solar (“PubCo”) intends to file with the U.S. Securities and Exchange Commission (the “SEC”) and make available to Blue World’s shareholders, a post-effective amendment to the Registration Statement on Form F-4 of PubCo, as amended (File No. 333-277779) (the “Registration...

Continue reading

Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights

– RECOVER-1 Phase 3 global trial successfully met all primary and secondary endpoints with statistically significant reductions across all major symptom domains in schizophrenia – – Initiation of registrational RECOVER-2 trial expected in the second quarter of 2024; topline data expected Q2 2025 – – Topline data from 1-year open-label extension (OLE) trial expected Q4 2024 – – Most non-clinical activities completed and preparation is underway to support a New Drug Application (NDA) submission for brilaroxazine in schizophrenia targeted for Q3 2025 – CUPERTINO, Calif., April 15, 2024 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory...

Continue reading

Microchip Technology Acquires Neuronix AI Labs

Innovative technology enhances AI-enabled intelligent edge solutions and increases neural networking capabilities CHANDLER, Ariz., April 15, 2024 (GLOBE NEWSWIRE) — Microchip Technology (Nasdaq: MCHP) has acquired Neuronix AI Labs to expand its capabilities for power-efficient, AI-enabled edge solutions deployed on field programmable gate arrays (FPGAs). Neuronix AI Labs provides neural network sparsity optimization technology that enables a reduction in power, size and calculations for tasks such as image classification, object detection and semantic segmentation, while maintaining high accuracy. Microchip’s mid-range PolarFire® FPGAs and SoCs already lead the industry in terms of low power consumption, reliability and security capabilities. The acquisition of this technology will enable Microchip to develop cost-effective, large-scale...

Continue reading

Solar Alliance first quarter corporate update shows continued growth for commercial solar

Small and medium-sized project growth accelerating in addition to continued large project momentum TORONTO and KNOXVILLE, Tenn., April 15, 2024 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR), a leading solar energy solutions provider focused on the commercial and industrial solar sector, is pleased to provide a corporate update for the first quarter of 2024. “The first quarter has seen our team execute on several large projects and continue the sales growth that we experienced last year. We remain committed to growing the Company with an emphasis on profitability and we believe our business plan and contracted backlog support this strategy moving forward. The Solar Alliance team continues to see increased demand for commercial solar projects, and we remain focused on larger, higher...

Continue reading

G2 Goldfields Provides Exploration Update

TORONTO, April 15, 2024 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX: GTWO; OTCQX: GUYGF) is pleased to provide an update on the ongoing exploration program at the Company’s 27,719 acre OKO-AREMU gold project. G2 recently announced an updated Mineral Resource Estimate (“MRE”) for the OKO-Aremu Project comprised of 922,000 ounces of gold (“Indicated”) and 1,099,000 ounces of gold (“Inferred”) [see press release dated April 03, 2024]. The entirety of the reported gold resource lies within 500 meters of surface and contains a high grade core of 688,000 ounces Au at 9.03 g/t Au (Indicated) and 495,000 ounces Au at 6.38 g/t Au (Inferred) at the OKO MAIN ZONE (OMZ). Recent drill results confirm the prospectivity of the area between the high grade OMZ resource and Ghanie open pit area, approximately 1 km to the south....

Continue reading

Banle Energy International Limited Supports Yang Ming’s inaugural B24 Biofuel Bunkering Services in Yantian, Shenzhen

HONG KONG, April 15, 2024 (GLOBE NEWSWIRE) — On April 14, 2024, Banle Energy International Limited, a subsidiary of the Banle Group (NASDAQ: BANL), a reputable marine fuel logistic company in the Asia Pacific region, in collaboration with PetroChina Fuel Oil Co. Ltd., is delighted to announce the arrangement of B24 biofuel bunkering services for Yang Ming’s vessel, YM Utility, at a port in Yantian, Shenzhen. By providing Yang Ming with our B24 biofuel bunkering services, this transaction supports the first B24 biofuel supply in Shenzhen and Yang Ming’s inaugural B24 biofuel bunkering supply in China. As a company actively promoting the use of biofuels, we are making a significant contribution to the International Maritime Organization’s (IMO) goal of reducing greenhouse gas emissions (GHG) from international shipping. The...

Continue reading

Bio-Path Holdings Expands Global Patent Portfolio

Builds on Global Intellectual Property Portfolio to Protect DNAbilize® Platform HOUSTON, April 15, 2024 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced the receipt of newly issued patents in Mexico, Australia and Japan, and updated investors on the extent of its global intellectual property portfolio. Bio-Path has expanded its intellectual property portfolio by filing patent applications that are applicable to its technology and business strategy. Bio-Path’s patent portfolio currently includes five issued patents in the U.S. and 54 issued patents in foreign jurisdictions, providing protection in 21 countries. “We continue our efforts to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.